Company Description

NewGenIvf Group Limited provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan.

Its services includes mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, mrt techniques, in-vitro fertilization /ICSI, hysteroscopy, semen analysis, TESE/TESA/PESA, embryo transfer, egg freezing, and chromosome screening, as well as surrogacy and ancillary caring services.

The company was founded in 2010 and is based in Central, Hong Kong.

NewGenIvf Group Limited

Country	Hong Kong
Founded	2011
Industry	Medical Care Facilities
Sector	Healthcare
Employees	70
CEO	Wing Fung Siu

Contact Details

Address: Pier 2, 1st Floor Central, 999077 Hong Kong
Phone	212-537-4406
Website	newgenivf.com

Stock Details

Ticker Symbol	NIVF
Exchange	NASDAQ
Stock Type	Common Stock
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001981662
ISIN Number	VGG0544E1051
SIC Code	8090

Key Executives

Name	Position
Wing Fung Siu	Co-Founder, Chairman and Chief Executive Officer
Hei Yue Fong	Co-Founder, Chief Marketing Officer and Director
Fai Chung Ho	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Mar 7, 2025	F-1	Registration statement for certain foreign private issuers
Feb 20, 2025	6-K	Report of foreign issuer
Feb 20, 2025	6-K	Report of foreign issuer
Feb 7, 2025	6-K/A	Filing
Jan 31, 2025	6-K	Report of foreign issuer
Jan 21, 2025	6-K	Report of foreign issuer
Dec 9, 2024	EFFECT	Notice of Effectiveness
Dec 5, 2024	SC 13G	Statement of acquisition of beneficial ownership by individuals
Dec 5, 2024	F-1/A	[Amend] Registration statement for certain foreign private issuers
Dec 3, 2024	6-K	Report of foreign issuer

View All SEC Filings